Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a “humanized” G6PD A- mouse model

Background Hydroxychloroquine (HCQ) is widely used in the treatment of malaria, rheumatologic disease such as lupus, and most recently, COVID-19. These uses raise concerns about its safe use in the setting of glucose-6-phosphate dehydrogenase (G6PD) deficiency, especially as 11% of African American...

Full description

Bibliographic Details
Main Authors: Benjamin E. Zuchelkowski, Ling Wang, Sebastien Gingras, Qinzi Xu, Minying Yang, Darrell Triulzi, Grier P. Page, Victor R. Gordeuk, Daniel B. Kim-Shapiro, Janet S. Lee, Mark T. Gladwin, Patrick G. Gallagher
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531777/?tool=EBI